Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹İnönü Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Malatya, Yrd. Doç. Dr.
²İnönü Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Malatya, Prof. Dr
³İnönü Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Malatya, Asist. Dr.
⁴Elbistan Devlet Hastanesi, Göz Hastalıkları Kliniği, Kahramanmaraş, Uz. Dr.
⁵Malatya Devlet Hastanesi, Göz Hastalıkları Kliniği, Malatya, Uz. Dr. Central retinal vein occlusion (RVO) is the second most common retinal vascular disease after diabetic retinopathy and is a common cause of visual morbidity. Most of the patients who develop CRVO are over 50 years. The pathogenesis, risk factors and treatment of CRVO in younger patients, are still poorly understood. In this case report, and literature review three young patients with CRVO were presented. After a complete ophthalmic examination, patients were gone through a medical assesment for underlying systemic causes. Intravitreal 1.25 mg/0.1 ml bevacizumab injection were performed to two patients and 4 mg/0.1 ml triamcinolone injection was performed to one patient for the macular edema due to CRVO. Visual and anatomic success was provided with intravitreal bevacizumab injection, and we did not see any complication due to this treatment. The patient treated with intravitreal triamcinolone injection also had visual and anatomic success although seconder glaucoma and cataract were detected in his follow-up visits. Trabeculectomy and cataract surgery in different seance were performed. Keywords : Central retinal vein occlusion, bevacizumab, triamcinolone